Transactivation of the human MDR1 gene by hepatitis B virus X gene product

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 872-878

  Doong, Shin Lian ^a,b   Lin, Mei Hui ^a   Tsai, Ming Ming ^a   Li, Tz Rung ^a   Chuang, Shuang En ^b   Cheng, Ann Lii ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis B virus; Multidrug resistance (MDR); PX

Indexed keywords

DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GENE PRODUCT; TRANSACTIVATOR PROTEIN; VINBLASTINE; VIRUS PROTEIN;

ARTICLE; DRUG SENSITIVITY; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS CARCINOGENESIS;

EID: 0032403863     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80113-X     Document Type: Article

References (32)

1. 1. Beasley RP, Lin CC, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981; ii: 1129-32.
2. 2. Ganem D, Varmus HE. The molecular biology of hepatitis B virus. Ann Rev Biochem 1987; 56: 651-93.
3. 3. Henkler F, Koshy R. Multiple functions of the hepatitis B virus X protein. Viral Hepatitis 1996; 2: 143-59.
4. 4. Cross JC, Wen P, Rutter WJ. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci (USA) 1993; 90: 8078-82.
5. 5. Kekule AS, Laurer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway. Nature (Lond.) 1993; 361: 742-5.
6. 6. Natoli G, Avantaggiati ML, Chirillo P, Puri P, Ianni A, Balsano C, et al. Ras-and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994; 9: 2837-43.
7. 7. Natoli G, Avantaggiati ML, Chrillo P, De Marzio E, Collepardo D, Falco M, et al. Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX. J Hepatol 1995; 22: 14-20.
8. 8. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
9. 9. Cole SPC, Bhaardwai G, Geriach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC) 1992; 258: 1650-4.
10. 10. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
11. 11. Wang C-Y, Mayo MW, Baldwin AS. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science (Washington DC) 1996; 274: 784-7.
12. 12. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-52.
13. 13. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
14. 14. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-42.
15. 15. Feitelson MA, Zhu M, Duan L-X, London WT. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993; 8: 1109-17.
16. 16. Traunt R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 1995, 69: 1851-9.
17. 17. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu J-R, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci (USA) 1994; 91: 2230-4.
18. 18. Chin KV, Ueda K, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science (Washington DC) 1992; 255: 459-62.
19. 19. Zastawny RL, Salvino R, Chen J, Benchimol S, Ling V. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene 1993; 8: 1529-35.
20. 20. Goldsmith M, Gudas JM, Schneider E, Cowan KH. Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J Biol Chem 1995; 270: 1894-8.
21. 21. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, et al, p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 1993; 14: 987-92.
22. 22. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993; 85: 632-9.
23. 23. Chin K-V, Tanaka S, Darlington G, Pastan I, Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 1990; 265: 221-6.
24. 24. Tanimura H, Kohno K, Sato S-I, Uchiumi T, Miyazaki M, Kobayashi M, et al. The human multidrug resistance 1 promoter has an element that responds to serum starvation. Biochem Biophys Res Commun 1992; 183: 917-24.
25. 25. Chaudhary PM, Roninson IB. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonist. Oncol Res 1992; 4: 281-90.
26. 26. Seto E, Zhou DX, Peterlin BM, Yen TS. Transactivation by the hepatitis B virus X protein shows cell-type specificity. Virology 1989; 173: 764-6.
27. 27. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher H-W, et al, Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995; 55: 6012-6.
28. 28. Su F, Schneider RJ. Hepatitis B virus HBx activates transcription factor NF-kB by acting on multiple cytoplamsic inhibitors of rel-related proteins. J Virol 1996; 70: 4558-66.
29. 29. Oshikawa O, Tamura S, Kawata S, Ito N, Tsushima H, Kiso S, et al.The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-β1. Biochem Biophys Res Commun 1996; 222: 770-3.
30. 30. Capovilla A, Carmona S, Arbuthnot P. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun 1997; 232: 255-60.
31. 31. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci (USA) 1997; 94: 8162-7.
32. 32. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor a. Proc Natl Acad Sci (USA) 1997; 94: 8744-9.